10JulGood News | BioEngine Sci-Tech Co, Ltd’s Vigor-S101S Serum-Free Medium For In...Recently, Vigor-S101S Serum-Free Medium for Insect Cells and its matched supplement independently developed by BioEngine Sci-Tech Co, Ltd have offi...
view more
09JulAs May Draws To A Close, BioEngine Sci-Tech Co, Ltd Keeps Accelerating Its Gl...May enters its final week, yet BioEngine Sci-Tech Co, Ltd shows no sign of slowing down. From Nanjing to Beijing in China, then onward to Makuhari ...
view more
13MayBioEngine Launches UltraFeed CHO Supplement, Boosting Titers By Up To 48%SHANGHAI, April 15, 2026 –Shanghai BioEngine Sci-tech Co., Ltd. recently announced the launch of UltraFeed, a next-generation fed-batch suppl...
view more
29JanThe Evolution Of Influenza Vaccine Production: MDCK Cell-Driven, Breaking The...Manufacturing Process of Influenza Virus Vaccines Recently, respiratory diseases have entered a high-incidence period, with a superposition of mult...
view more
22NovQ&A | Solutions To Questions On Lactate Metabolism Regulation Strategies in C...Q&A on Lactate Metabolism Regulation Strategies in Cell Culture Last week, BioEngine launched a live webinar series themed "Intelligent Ma...
view more
29JanProduct Introduction: Eden Series CHO Cell CD MediumEden Series Products Product Features Serum-free, protein-free, animal-origin-free, with a chemically defined composition Suitable for CHO-K1, CHOZ...
view more
28JanNews Update | Tecelra, The World’s First TCR-T Therapy, Launches With Remarka...NEWS Recently, Adaptimmune announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for its TCR-T therapy Tecelr...
view more
28NovQ&A Session: Development And Application Of Insect Baculovirus System in Gene...Panda Classroom launched the CGT Lecture Series in OctoberIn October, Panda Classroom launched the CGT Lecture Series, aiming to provide a learning...
view more
30MayStrategies For Enhancing Transient Protein Expression in CHO CellsThe well-known Chinese Hamster Ovary (CHO) cells are widely used in the production of therapeutic proteins such as antibodies and recombinant prote...
view more
27JanQ&A Session After Class | Strategies And Technical Challenges For Efficient M...In the 4th Session of "Panda Class – CGT Series Lectures" We invited Dr. Chen Min, R&D Director of BioEngine, to deliver a them...
view more
14NovQ&A Session After Class | Unlocking The Code For Cost Reduction And Efficienc...On November 7th, we held the 2nd Session of Panda Class – CGT Series Lectures. For this session, we specially invited Dr. Xu Lei from Obio Te...
view more













